Lyngby, Denmark

Morten Bang Nørgaard



Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Morten Bang Nørgaard: Innovator in Pharmaceutical Chemistry

Introduction

Morten Bang Nørgaard is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors implicated in various disorders. With a total of 4 patents to his name, Nørgaard's work is recognized for its potential therapeutic applications.

Latest Patents

Nørgaard's latest patents include innovative compounds that serve as NK3 receptor antagonists. One of his notable inventions is the cyclopropyl derivatives of formula (I) and their salts. These compounds are designed to be useful in treating diseases where the NK3 receptor is implicated, such as psychotic disorders. Another significant patent involves the uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives, which are aimed at treating affective disorders.

Career Highlights

Throughout his career, Morten Bang Nørgaard has worked with prominent companies in the pharmaceutical industry, including H. Lundbeck A/S. His expertise in receptor-targeted therapies has positioned him as a valuable contributor to advancements in mental health treatments.

Collaborations

Nørgaard has collaborated with several professionals in his field, including Jan Kehler and Karsten Juhl. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.

Conclusion

Morten Bang Nørgaard's contributions to pharmaceutical chemistry highlight his role as an inventor dedicated to improving treatment options for various disorders. His innovative patents and collaborations reflect a commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…